Pakistan signs agreement with WHO to access free childhood cancer medicines
ISLAMABAD: Pakistan has signed a landmark agreement with the World Health Organization (WHO) to provide free cancer medicines for children, becoming the second country in the Eastern Mediterranean Region to join the Global Platform for Access to Childhood Cancer Medicines.
The initiative, co-founded in 2021 by St. Jude Children’s Research Hospital and WHO, seeks to address the critical shortage of treatment in low- and middle-income countries (LMICs). Over 8,000 new childhood cancer cases are diagnosed annually in Pakistan, yet limited access to quality medicines has kept survival rates as low as 30%, compared to nearly 80% in high-income countries.
The agreement was signed by Federal Health Minister Syed Mustafa Kamal and WHO Representative in Pakistan Dr. Dapeng Luo. It will remain in effect until 31 December 2027, with an option for extension. Under the agreement:
- Pakistan will receive an uninterrupted supply of certified, quality-assured cancer medicines free of cost.
- UNICEF will oversee procurement and delivery of medicines.
- WHO will continue providing technical guidance, operational support, and resources to strengthen Pakistan’s childhood cancer care.
Global burden and Pakistan’s commitment
Globally, an estimated 400,000 children develop cancer every year, with 90% living in LMICs. Survival rates remain below 30%, meaning seven out of ten children do not survive due to limited access to treatment.
“Today is a big day for Pakistan, because through this agreement we are going to receive medicines to treat children who have cancer. This is the way forward… If we are able to save one life through this collaboration, we are saving mankind,” said Health Minister Syed Mustafa Kamal.
Dr. Dapeng Luo reaffirmed WHO’s support, stating: “No child affected by cancer should die because of lack of access to treatment. WHO will work side by side with the Ministry of Health and partners to save lives and leave no child behind.”
A step toward improved survival
The Global Platform aims to raise childhood cancer survival rates in Pakistan from 30% to 60% by 2030, bringing the country closer to international standards and offering hope to thousands of families affected by pediatric cancer.
Stay informed. Stay ahead.
CLICK HERE TO FOLLOW Medical News Pakistan WhatsApp Channel for trusted healthcare updates, expert insights, clinical research, policy news, and medical breakthroughs—delivered directly to you.